You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.
The company said the test achieved 100 sensitivity and 100 percent specificity in a study of 210 samples that included 44 from COVID-19 patients.
The partners' "COVID-19 task force" will invest in ePlex molecular testing platforms from GenMark Diagnostics to quadruple UCSF's testing capacity.
Genomica, a PharmaMar Group company, has developed kits based on real-time PCR and its CLART low-density microarray technology.
The firm said it took in $33.6 million in product and service revenue in the quarter, a 42 percent increase from $23.6 million in Q4 2018.
The microarray runs on the company's CE marked Mosaiq system for blood grouping and transfusion-transmitted infection screening.